Tai-Shin Pharmaceutical Q4 2025 Financial Report
NQ Score
60/100
N1 Content Completeness
8
AI Summary (NQ-processed)
Tai-Shin Pharmaceutical Co., Ltd. reported a basic EPS of -0.55 NTD and an operating revenue of 0.09 billion NTD for Q4 2025, with a net loss after tax of 0.84 billion NTD.
AI analysis data is not yet available.